These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7625674)

  • 21. [Development studies of lyophilized standard diphtheria-tetanus-pertussis vaccines].
    Ozcengiz E; Unver D; Cayan HH; Atakan Ablay P; Kanik E
    Mikrobiyol Bul; 2007 Apr; 41(2):165-73. PubMed ID: 17682702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bordetella parapertussis infections.
    Mastrantonio P; Giuliano M; Stefanelli P; Sofia T; De Marzi L; Tarabini G; Quarto M; Moiraghi A
    Dev Biol Stand; 1997; 89():255-9. PubMed ID: 9272358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age.
    Booy R; Aitken SJ; Taylor S; Tudor-Williams G; Macfarlane JA; Moxon ER; Ashworth LA; Mayon-White RT; Griffiths H; Chapel HM
    Lancet; 1992 Feb; 339(8792):507-10. PubMed ID: 1346876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diphtheria, tetanus and pertussis antibodies in 10-year-old children before and after a booster dose of three toxoids: implications for the timing of a booster dose.
    Trollfors B; Knutsson N; Taranger J; Mark A; Bergfors E; Sundh V; Lagergård T
    Eur J Pediatr; 2006 Jan; 165(1):14-8. PubMed ID: 16249929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator.
    Ladhani SN; Andrews NJ; Southern J; Jones CE; Amirthalingam G; Waight PA; England A; Matheson M; Bai X; Findlow H; Burbidge P; Thalasselis V; Hallis B; Goldblatt D; Borrow R; Heath PT; Miller E
    Clin Infect Dis; 2015 Dec; 61(11):1637-44. PubMed ID: 26374816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis.
    Ausiello CM; Urbani F; La Sala A; Lande R; Piscitelli A; Cassone A
    Dev Biol Stand; 1997; 89():315-20. PubMed ID: 9272365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pertussis vaccine and encephalopathy, an Irish case.
    Brahams D
    Lancet; 1991 Aug; 338(8762):305. PubMed ID: 1677124
    [No Abstract]   [Full Text] [Related]  

  • 28. Diphtheria, tetanus, pertussis: antibody detection in New Zealand.
    Lau RC
    N Z Med J; 1987 Aug; 100(829):481-3. PubMed ID: 3502676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis.
    Arciniega JL; Hewlett EL; Johnson FD; Deforest A; Wassilak SG; Onorato IM; Manclark CR; Burns DL
    J Infect Dis; 1991 Jan; 163(1):135-42. PubMed ID: 1984460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No adverse impact on protection against pertussis from combined administration of Haemophilus influenza type b conjugate and diphtheria-tetanus toxoid-pertussis vaccines in the same syringe.
    Levine OS; Lagos R; Losonsky GA; San Martin O; Abrego P; Bustamante C; Wasserman SS; Levine MM
    J Infect Dis; 1996 Dec; 174(6):1341-4. PubMed ID: 8940230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dot immunoassay for the simultaneous determination of postvaccination immunity against pertussis, diphtheria, and tetanus.
    Khramtsov P; Bochkova M; Timganova V; Zamorina S; Rayev M
    Anal Bioanal Chem; 2017 Jun; 409(15):3831-3842. PubMed ID: 28374129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternative diphtheria, tetanus and whooping cough immunization schedule to evoke a Th2 tetanus and a Th1 pertussis immune response.
    Lavigne MV; Castro M; Andino J; Manghi M
    Microbes Infect; 2004 Apr; 6(5):481-4. PubMed ID: 15109963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistence of antibodies at 5-6 years of age for children who had received a primary series vaccination with a pentavalent whole-cell pertussis vaccine and a first booster with a pentavalent acellular pertussis vaccine: immunogenicity and tolerance of second booster with a tetravalent acellular vaccine at 5-6 years of age.
    Langue J; Matisse N; Pacoret P; Undreiner F; Boisnard F; Soubeyrand B;
    Vaccine; 2004 Mar; 22(11-12):1406-14. PubMed ID: 15063563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous administration of diphtheria/tetanus/pertussis/polio vaccine and hepatitis B vaccine in a simplified immunization programme.
    Coursaget P; Yvonnet B; Relyveld EH; Barres JL; Diop-Mar I; Chiron JP
    Dev Biol Stand; 1986; 65():169-75. PubMed ID: 2881821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of adjuvant effect of the pertussis component on IPV DTP-polio vaccine in children.
    Cadoz M; Montagnon B; Yvonnet B; Xueref C; Vincent-Falquet JC; Bandet R; Gibelin N
    Dev Biol Stand; 1986; 65():153-8. PubMed ID: 2881819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of maternal vaccination against diphtheria, tetanus, and pertussis on the avidity of infant antibody responses to a pertussis containing vaccine in Belgium.
    Caboré RN; Maertens K; Dobly A; Leuridan E; Van Damme P; Huygen K
    Virulence; 2017 Oct; 8(7):1245-1254. PubMed ID: 28277900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune responses to pertussis vaccines concurrently administered with viral vaccines.
    Halperin SA; Eastwood BJ; Langley JM
    Ann N Y Acad Sci; 1995 May; 754():89-96. PubMed ID: 7625684
    [No Abstract]   [Full Text] [Related]  

  • 38. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and composition of acellular pertussis vaccines. Consideration of potential effects on vaccine efficacy.
    Hewlett EL
    Dev Biol Stand; 1997; 89():143-51. PubMed ID: 9272344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity issues in the quality control of the new acellular pertussis vaccines.
    Mastrantonio P; Cerquetti M; Cardines R; Lande R; Ausiello CM; Cassone A
    Biologicals; 1999 Jun; 27(2):119-21. PubMed ID: 10600199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.